Daily non-political popular news in brief.
Standard long-acting insulin as good as newer medications
04-17-2007 · EurekAlert!An older type of long-acting insulin is as effective in treating type 2 diabetes as newer and more expensive kinds, according to the results of a recent systematic review. However, the newer medications may cause fewer problems with low blood glucose while patients are sleeping.
Read more »
Keywords: standard, long-acting, insulin, good, newer, medications, long, acting, medication
« Previous | Next »
Similar news on "Standard long-acting insulin as good as newer medications":
- Manic phase of bipolar disorder benefits from breast cancer medication
09-12-2007 · EurekAlert!
The manic phase of bipolar disorder favors destructive behaviors. Stemming it quickly is important. Tamoxifen's effects were dramatic -- 63 percent of patients responded vs. 13 percent on placebo -- and it kicked in faster than many current medications. Tamoxifen skips some of current drugs' biochemical steps and acts directly on the enzyme protein-kinase C, giving scientists a more direct target at which to aim new medications in their search for faster-acting treatments.
Similar news · Read more »
- Older medication may be more cost-effective for some patients with schizophrenia
12-01-2006 · EurekAlert!
A new study analyzing the economic implications of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) concludes that the older (first generation) antipsychotic medication perphenazine was less expensive and no less effective than the newer (second generation) medications used in the trial during initial treatment, suggesting that older antipsychotics still have a role in treating schizophrenia.
Similar news · Read more »
- Mayo Clinic researchers: Insulin-boosting medication does not impair ability to survive heart attack
11-05-2007 · EurekAlert!
Mayo Clinic researchers helped clarify a growing concern about the link between diabetes mellitus treatments and heart attack with the first large, population-based study showing that a group of common medications does not reduce diabetic patients' heart attack survival rates.
Similar news · Read more »
- Use of insulin pen may save diabetics thousands of dollars
08-20-2007 · EurekAlert!
Diabetics who need to switch from oral medications to insulin could reduce their annual health care costs up to $17,000 by using an insulin pen instead of a syringe to deliver their daily dose of medication. A new study found that using an insulin pen may result in fewer trips to the emergency department and to the doctor's office, resulting in substantial savings to diabetics and their insurers.
Similar news · Read more »
- Use of diabetes medication by older adults linked with increased risk of heart problems, death
12-11-2007 · EurekAlert!
Older patients treated with the diabetes medications known as thiazolidinediones (which include rosiglitazone) had a significantly increased risk of heart attack, congestive heart failure and death, compared with the use of other hypoglycemic drugs, according to a study in the Dec. 12 issue of JAMA. The authors suggest that these results provide further evidence that this class of medication may cause more harm than good.
Similar news · Read more »
- Cholesterol-lowering drugs don't offset healthy choices, study finds
08-01-2007 · EurekAlert!
Within the medical field, it is often assumed that patients view cholesterol-lowering medications (or statins) as a license to eat whatever they like -- they figure their medication has them covered, so a steak here and there won't hurt. However, a study published in the August issue of Mayo Clinic Proceedings finds that such patients don't tend to adopt unhealthy diets when prescribed statins.
Similar news · Read more »
- Lowering body temperature could aid standard stroke treatment
05-17-2007 · EurekAlert!
University of Cincinnati scientists have developed a model that could help physicians combine current clot-busting medication with below-normal body temperatures (hypothermia) to improve the treatment of ischemic stroke patients.
Similar news · Read more »
- Novel medication improves ovarian cancer treatment
10-31-2007 · EurekAlert!
A new study appearing in International Journal of Gynecological Cancer states that Bevacizumab, a biologic anticancer agent that prevents tumor growth by interfering with the formation of new blood vessels, may have the potential to improve the efficacy of standard combination chemotherapy in ovarian cancer.
Similar news · Read more »
- Duke researchers find physician resistance hinders diabetics use of cutting edge technology
10-13-2006 · EurekAlert!
Diabetic patients who use newer technologies such as insulin pumps and blood glucose monitoring devices are better able to manage their disease and adhere to treatment regimens, with less daily pain, than with conventional treatments, according to Duke University researchers. Yet researchers have found that the newer methods to manage diabetes are not being widely used because physicians may be reluctant to prescribe them, and even patients who are using them may not be deriving their full benefits.
Similar news · Read more »
- Women prescribed drugs linked to birth defects not often advised to use birth control
09-17-2007 · EurekAlert!
Although prescription medications that may increase the risk of birth defects are commonly used by women in their childbearing years, only about half receive contraceptive counseling from their health-care providers, according to a large-scale study from the University of Pittsburgh School of Medicine. The study found that one in six women of reproductive age filled a prescription for a medication labeled by the FDA as increasing the risk of fetal abnormalities.
Similar news · Read more »
